Back to Search
Start Over
HGF and IGF-1 synergize with SDF-1α in promoting migration of myeloma cells by cooperative activation of p21-activated kinase.
- Source :
-
Experimental hematology [Exp Hematol] 2013 Jul; Vol. 41 (7), pp. 646-55. Date of Electronic Publication: 2013 Mar 14. - Publication Year :
- 2013
-
Abstract
- Stromal-derived factor (SDF)-1α, insulin-like growth factor (IGF)-1 and hepatocyte growth factor (HGF) are potent mediators of cell migration. We studied the effect of combinations of these cytokines on the migration of myeloma cells. When SDF-1α was combined with either HGF or IGF-1, we found a striking synergy in the cytokines' ability to guide cells across a transwell membrane. Between HGF and IGF-1 there was no cooperativity. However, the effects of HGF and IGF-1 were not redundant. HGF and SDF-1 caused concentration gradient-directed migration, as opposed to IGF-1, which apparently caused randomly directed cell movement. The SDF-1α-driven migration of JJN-3 cells, a myeloma cell line secreting large amounts of HGF, was reduced when JJN-3 cells were given an inhibitor of the HGF receptor, demonstrating a cooperative activity between autocrine HGF and exogenous SDF-1α. There was a clear positive correlation between the degree of cytokine-induced migration and phosphorylation of p21-activated kinase (PAK) both in primary myeloma cells and in cell lines including INA-6 and IH-1. Downregulation of PAK with small interfering RNA in INA-6 cells resulted in decreased cytokine-driven migration. This study shows synergy between SDF-1α and HGF/IGF-1 in inducing migration of myeloma cells, yet each cytokine has distinct properties in the way it regulates cell migration. These findings are likely to be of clinical relevance because multiple myeloma cells are located in an environment containing HGF and IGF-1 and are exposed to an SDF-1α gradient between the bone marrow and peripheral blood.<br /> (Copyright © 2013 ISEH - Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.)
- Subjects :
- Autocrine Communication
Cell Line, Tumor
Cell Movement drug effects
Chemokine CXCL12 physiology
Dose-Response Relationship, Drug
Drug Synergism
Enzyme Activation
Hepatocyte Growth Factor physiology
Humans
Insulin-Like Growth Factor I physiology
Neoplasm Proteins physiology
Proto-Oncogene Proteins c-met drug effects
RNA, Small Interfering pharmacology
Receptors, CXCR4 physiology
Recombinant Fusion Proteins physiology
Transfection
p21-Activated Kinases antagonists & inhibitors
p21-Activated Kinases genetics
Chemokine CXCL12 pharmacology
Hepatocyte Growth Factor pharmacology
Insulin-Like Growth Factor I pharmacology
Multiple Myeloma pathology
p21-Activated Kinases physiology
Subjects
Details
- Language :
- English
- ISSN :
- 1873-2399
- Volume :
- 41
- Issue :
- 7
- Database :
- MEDLINE
- Journal :
- Experimental hematology
- Publication Type :
- Academic Journal
- Accession number :
- 23499762
- Full Text :
- https://doi.org/10.1016/j.exphem.2013.03.002